ERBB2 and breast carcinoma: Overall, HER2 IHC scores of 2+ and 3+ breast cancer patients were predominant in Malay (54/59, 91.5%), of the age group of less than 55 years (31/59, 52.5%), and of tumour size between 20 mm to 49 mm (34/59, 57.6%).